Press Releases
ALPHARETTA, Ga., July 22, 2019 /PRNewswire/ -- Velan Capital, L.P. (together with the other members of its group, "Velan" or "we"), one of the largest stockholders of Progenics Pharmaceuticals, Inc. ("Progenics" or the "Company")(NASDAQ: PGNX), comprised of successful specialty pharmaceutical operators and financial services experts, today announced that the final result
Read more...ATLANTA, July 22, 2019 /PRNewswire/ -- DLH Holdings Corp. (NASDAQ: DLHC) ("DLH" or the "Company"), a leading provider of innovative healthcare services and solutions to federal agencies, today announced that it will participate in the Canaccord Genuity 39th Annual Growth Conference on August 7, 2019 in
Read more...22 July 2019
CHICAGO, July 22, 2019 /PRNewswire/ -- Aptus Exchange ("AE"), a leading health care advisory firm, announced that Dr. Peter Norvid has been hired as the Chief Medical Officer on the organization's executive team. Dr. Norvid joins AE to provide strategic guidance to the organization and consulting services to its clients.
Read more...NEENAH, Wis., July 22, 2019 /PRNewswire/ -- TIDI Products, LLC, a leading provider of medical technology solutions including Sterile-Z®, C-Armor®, TIDIShield®, and Posey®, today announced the addition of PenBlade®, a single-use safety scalpel, to its portfolio of acute care consumables focused on
Read more...22 July 2019
TWINSBURG, Ohio, July 22, 2019 /PRNewswire/ -- The CEIA USA Ferromagnetic Division, a provider of ferromagnetic detection systems, expanded its solutions for the healthcare industry with the new CEIA MSDW wall-mounted and CEIA MSDH portable ferromagnetic detectors. These systems provide fast, simple and effective analysis fo
Read more...22 July 2019
NEW HAVEN, Conn., July 22, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today announced that enrollment in the T2 Protect AD Study, a Phase 2/3 clinical trial of troriluzole i
Read more...EAST HANOVER, N.J., July 22, 2019 /PRNewswire/ -- Novartis is teaming up with celebrity interior designer Nate Berkus to launch My Home in Sight, a program that aims to raise awareness of the daily impact of wet age-related macular degeneration (wet AMD) and empower those living with wet AMD and their caregivers to make s
Read more...22 July 2019
VAUGHAN, ON, July 22, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST
Read more...WASHINGTON, July 22, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that on July 19, 2019, it received a notification from the U.S. Food and Drug Administration (FDA) stating that as part of its ongoing review of Vanda's supplemental New Drug Application (sNDA) for HETLIOZ® (ta
Read more...JERSEY CITY, N.J., July 22, 2019 /PRNewswire/ -- Legal-Bay LLC, The Pre Settlement Funding Company, announced today that they have recently seen an increase in Essure birth control lawsuits, and are preparing for numerous presettlement payouts in the coming months.
Read more...